Ghrelin/Leptin-Imbalance in Patients with Primary Biliary Cirrhosis

Abstract

Background

The recently discovered peptide hormone ghrelin mainly produced in gastric oxyntic cells may act as a counterpart to leptin in the regulation of food intake and fat utilization. Leptin, involved in the stimulation of proinflammatory cytokines and catabolic energy balance, is elevated in patients with liver cirrhosis. In the present study, we evaluated serum ghrelin and bound leptin levels in patients with primary biliary cirrhosis (PBC) in relation to C-peptide and glucose concentration.

Methods

In 22 female patients with PBC (Child-Pugh stage A) and in 36 female controls we measured serum ghrelin, bound leptin, and C-peptide levels using specific immunoassays.

Results

In comparison to controls serum bound leptin levels were significantly higher in patients with PBC (p < 0.01) whereas serum ghrelin levels were decreased compared to the control group (p < 0.01). In parallel, C-peptide concentrations were increased (p < 0.01) with no significant change in circulating glucose levels.

Conclusion

Our data confirm in PBC patients that serum bound leptin levels are increased and clearly show a parallel decrease in serum ghrelin concentrations acting as a physiological counterpart to leptin. Furthermore, we suggest that these changes are linked to the insulin resistance observed in our patients.

Key words

Ghrelin - leptin - chronic liver disease

References

• 1 Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.  J Clin Endocrinol Metab. 2001;  86 4753-4758
• 2 Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino M A, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.  Gastroenterology. 2001;  120 337-345
• 3 Caixas A, Bashore C, Nash W, Pi-Sunyer F, Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects.  J Clin Endocrinol Metab. 2002;  87 1902
• 4 Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin.  Science. 1996;  274 1185-1188
• 5 Crespo J, Rivero M, Fabrega E, Cayon A, Amado J A, Garcia-Unzeta M T, Pons-Romero F. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis.  Dig Dis Sci. 2002;  47 1604-1610
• 6 Cummings D E, Weigle D S, Frayo R S, Breen P A, Ma M K, Dellinger E P, Purnell J Q. Plasma Ghrelin levels after diet-induced weight loss or gastric bypass surgery.  N Engl J Med. 2002;  346 1623-1630
• 7 Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal M S, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion.  Diabetes. 2002;  51 124-129
• 8 Doehner W, Rauchhaus M, Godsland I F, Egerer K, Niebauer J, Sharma R, Cicoira M, Florea V G, Coats A J, Anker S D. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.  Int J Cardiol. 2002;  83 73-81
• 9 Egido E M, Rodriguez-Gallardo J, Silvestre R A, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion.  Eur J Endocrinology. 2002;  146 241-244
• 10 Friedman J M, Hallaas J L. Leptin and the regulation of body weight in mammals.  Nature. 1998;  395 763-770
• 11 Gnanapavan S, Kola B, Bustin S A, Morris D G, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossmann A B, Korbonits M. The tissue distribution of the mRNA of Ghrelin and subtypes of its receptor, GHS-R, in humans.  J Clin Endocrinol Metab. 2002;  87 2988-2991
• 12 Guan X M, Yu H, Palyha O C, McKee K K, Feighner S D, Sirinathsinghji D J, Smith R G, Van der Ploeg L H, Howard A D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues.  Brain Res Mol Brain Res. 1997;  48 23-29
• 13 Howard A D, Feighner S D, Cully D F, Arena J P, Liberator P A, Rosenblum C I, Hamelin M, Hreniuk D L, Palyha O C, Anderson J, Paress P S, Diaz C, Chou M, Liu K K, McKee K K, Pong S S, Chaung L Y, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji D J, Dean D C, Melillo D G, Van der Ploeg L H. A receptor in pituitary and hypothalamus that functions in growth hormone release.  Science. 1996;  273 974-977
• 14 Kaplan L M. Leptin, obesity and liver disease.  Gastroenterology. 1998;  115 997-1001
• 15 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
• 16 Lee H M, Wang G, Englander E W, Kojima M, Greely Jr G H. Ghrelin, a new gastrointestinal peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations.  Endocrinology. 2002;  143 185-190
• 17 Leonhardt W, Horn R, Brabant G, Breidert M, Temelkova-Kurktschiew T, Fücker K, Hanefeld M. Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT).  Exp Clin Endocrinol Diabetes. 1999;  107 46-52
• 18 Lin S Y, Wang Y Y, Sheu W H. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.  Clin Endocrinol. 2002;  57 805-811
• 19 McCullough A J, Bugianesi E, Marchesini G, Kalhan S C. Gender-dependent alterations in serum leptin in alcoholic cirrhosis.  Gastroenterology. 1998;  115 947-953
• 20 McKee K K, Palyha O C, Feighner S D, Hreniuk D L, Tan C P, Phillips M S, Smith R G, Van der Ploeg L H, Howard A D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.  Mol Endocrinol. 1997;  11 415-423
• 21 Müller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes.  J Biol Chem. 1997;  272 10585-10593
• 22 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding.  Nature. 2001;  409 194-198
• 23 Ockenga J, Bischoff S C, Tillmann H L, Rifai K, Widjaja A, Böker K HW, Manns M P, Brabant G. Elevated bound leptin correlates with energy expenditure in cirrhotics.  Gastroenterology. 2000;  119 1656-1662
• 24 Saad M F, Bernaba B, Hwu C M, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R. Insulin regulates plasma ghrelin concentration.  J Clin Endocrinol Metab. 2002;  87 3997-4000
• 25 Schöfl C, Horn R, Schill T, Schlösser H W, Müller M J, Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2002;  87 4607-4610
• 26 Schwartz M W, Morton G J. Obesity: Keeping hunger at bay.  Nature. 2002;  418 595-597
• 27 Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal M S, Tanaka M, Nozoe S I, Hosoda H, Kangawa K, Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.  J Clin Endocrionol Metab. 2002;  87 240-244
• 28 Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.  Diabetes. 2001;  50 227-232
• 29 Stephens T W, Basinski M, Bristow P K. The role of neuropeptide Y in the anti-obesity action of the ob gene product.  Nature. 1995;  377 530-532
• 30 Tschöp M, Smiley D L, Heiman M L. Ghrelin induces adiposity in rodents.  Nature. 2000;  407 908-913
• 31 Willner I R, Waters B, Patil S R, Reuben A, Morelli J, Riely C. Ninety patients with nonalcoholic steatohepatitis: Insulin resistence, familial tendency, and severity of disease.  Am J Gastroenterol. 2001;  96 2957-2961
• 32 Weikel J C, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid D A, Uhr M, Steiger A. Ghrelin promotes slow-wave sleep in humans.  Am J Physiol Endocrinol Metab. 2003;  284 E407-415
• 33 Wren A M, Seal L J, Cohen M A, Brynes A E, Frost G S, Murphy K G, Dhillo W S, Ghatei M A, Bloom S R. Ghrelin enhances appetite and increases food intake in humans.  J Clin Endocrinol Metab. 2001;  86 5992
• 34 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue.  Nature. 1994;  372 425-432